Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure.

Aksu F, Capan N, Aksu K, Ofluoğlu R, Canbakan S, Yavuz B, Akin KO.

J Thorac Dis. 2013 Aug;5(4):414-21. doi: 10.3978/j.issn.2072-1439.2013.06.27.

3.

C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.

de Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, Celli BR, Casanova C.

Eur Respir J. 2006 May;27(5):902-7. Epub 2006 Feb 2.

4.

The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease.

Agarwal R, Zaheer MS, Ahmad Z, Akhtar J.

Multidiscip Respir Med. 2013 Sep 28;8(1):63. doi: 10.1186/2049-6958-8-63.

5.

C-reactive protein in patients with COPD, control smokers and non-smokers.

Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR.

Thorax. 2006 Jan;61(1):23-8. Epub 2005 Sep 2.

6.

[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].

Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.

Rev Med Chil. 2010 Aug;138(8):957-64. doi: /S0034-98872010000800003. Epub 2010 Nov 26. Spanish.

7.

Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.

Biljak VR, Rumora L, Cepelak I, Pancirov D, Popović-Grle S, Sorić J, Stjepanović G, Grubisić TZ.

Coll Antropol. 2013 Mar;37(1):221-7.

PMID:
23697277
8.

High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.

Liu SF, Wang CC, Chin CH, Chen YC, Lin MC.

Arch Bronconeumol. 2011 Sep;47(9):427-32. doi: 10.1016/j.arbres.2011.04.011. Epub 2011 Aug 6. English, Spanish.

9.

FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.

Montaño M, Sansores RH, Becerril C, Cisneros J, González-Avila G, Sommer B, Ochoa L, Herrera I, Ramírez-Venegas A, Ramos C.

Respir Res. 2014 Jun 30;15:74. doi: 10.1186/1465-9921-15-74.

10.

Systemic inflammation in patients with COPD and pulmonary hypertension.

Joppa P, Petrasova D, Stancak B, Tkacova R.

Chest. 2006 Aug;130(2):326-33.

PMID:
16899829
11.

Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification.

Lin YH, Wang WY, Hu SX, Shi YH.

Pak J Med Sci. 2016 Nov-Dec;32(6):1453-1458. doi: 10.12669/pjms.326.10905.

12.

[Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].

Long H, Luo H, Chen P, Li Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1090-6. doi: 10.3969/j.issn.1672-7347.2011.11.010. Chinese.

13.

[Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].

Solanes I, Bolíbar I, Llauger MA, Medrano C, Peiró M, Fraga M, Pou MA, Giner J, Freixas M, Plaza V; en nombre del Grupo de Investigación del Proceso EPOC.

Med Clin (Barc). 2012 Oct 20;139(10):430-6. doi: 10.1016/j.medcli.2012.03.033. Epub 2012 Jul 4. Spanish.

PMID:
22766062
14.

Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

Kwon YS, Chi SY, Shin HJ, Kim EY, Yoon BK, Ban HJ, Oh IJ, Kim KS, Kim YC, Lim SC.

J Korean Med Sci. 2010 Oct;25(10):1487-91. doi: 10.3346/jkms.2010.25.10.1487. Epub 2010 Sep 17.

15.

[C-Reactive protein levels in patients with chronic obstructive pulmonary disease].

Díaz O, Parada A, Ramos C, Klaassen J, Díaz JC, Andresen M, Lisboa C, Saldías F.

Rev Med Chil. 2012 May;140(5):569-78. doi: 10.4067/S0034-98872012000500003. Spanish.

16.

Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD.

Khan NA, Daga MK, Ahmad I, Mawari G, Kumar S, Kumar N, Husain SA.

J Inflamm Res. 2016 Nov 18;9:187-198. eCollection 2016.

17.

Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients.

Sarioglu N, Alpaydin AO, Coskun AS, Celik P, Ozyurt BC, Yorgancioglu A.

Multidiscip Respir Med. 2010 Apr 30;5(2):84-91. doi: 10.1186/2049-6958-5-2-84.

18.

The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.

Karadag F, Kirdar S, Karul AB, Ceylan E.

Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.

PMID:
18249305
19.

Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.

Pelegrino NR, Tanni SE, Amaral RA, Angeleli AY, Correa C, Godoy I.

Am J Med Sci. 2013 Jun;345(6):440-5. doi: 10.1097/MAJ.0b013e31825f32a7.

PMID:
22874622
20.

Epicardial fat thickness is associated with severity of disease in patients with chronic obstructive pulmonary disease.

Kiraz K, Gökdeniz T, Kalaycıoglu E, Börekçi A, Akyol S, Baykan AO, Acele A, Karakoyun S, Seker T, Gür M.

Eur Rev Med Pharmacol Sci. 2016 Nov;20(21):4508-4515.

Supplemental Content

Support Center